Suggested Readings

Antiretroviral therapy for the prevention of HIV-1 transmission.

Cohen MS, Chen YQ, McCauley M, et al. N Engl J Med. 2016;375(9):830-839.

Implementation of a rapid entry program decreases time to viral suppression among vulnerable persons living with HIV in the southern United States.

Colasanti J, Sumitani J, Mehta CC, et al. Open Forum Infect Dis. 2018;5(6):ofy104. 

Risk of cardiovascular disease associated with exposure to abacavir among individuals with HIV: A systematic review and meta-analyses of results from 17 epidemiologic studies.

Dorjee K, Choden T, Baxi SM, et al. Int J Antimicrob Agents. 2018;52(5):541-553.

Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association.

Feinstein MJ, Hsue PY, Benjamin LA, et al. Circulation. 2019;140(2):e98-e124.

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.

Friis-Møller N, Weber R, Reiss P, et al. AIDS. 2003;17(8):1179-1193.

Linkage and antiretroviral therapy within 72 hours at a Federally Qualified Health Center in New Orleans.

Halperin J, Butler I, Conner K, et al. AIDS Patient Care STDS. 2018;32(2):39-41.

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in a rapid-initiation model of care for human immunodeficiency virus type 1 infection: Primary analysis of the DIAMOND study.

Huhn GD, Crofoot G, Ramgopal M, et al. Clin Infect Dis. 2020;71(12):3110-3117.

Initiation of antiretroviral therapy in early asymptomatic HIV infection.

INSIGHT START Study Group, Lundgren JD, Babiker AG, et al. N Engl J Med. 2015;373(9):795-807.

The effect of same-day observed initiation of antiretroviral therapy on HIV viral load and treatment outcomes in a US public health setting.

Pilcher CD, Ospina-Norvell C, Dasgupta A, et al. J Acquir Immune Defic Syndr. 2017;74(1):44-51.

Global burden of atherosclerotic cardiovascular disease in people living with HIV: Systematic review and meta-analysis.

Shah ASV, Stelzle D, Lee KK, et al. Circulation. 2018;138(11):1100-1112.


Linked Resources

Clinical Practice Guidelines

Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people.

Deutsch MB, eds. University of California San Francisco.

Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society–USA panel.

Saag MS, Gandhi RT, Hoy JF, et al. JAMA. 2020;324(16):1651-1669.

Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV.

US Department of Health and Human Services

Clinical Resources

Adult Immunization Schedule.

Centers for Disease Control and Prevention. 

Patient Health Questionnaire-9 (PHQ-9).

National HIV Curriculum

North America Syringe Exchange Network.

Recommendation Topics.

United States Preventive Services Task Force.

Patient and Caregiver Resources

AIDSMap Resources

NAM Publications

Resources for persons living with HIV

Centers for Disease Control and Prevention

HIV resources

National Institutes of Health

Behavioral Health Treatment Services Locator

Substance Abuse and Mental Health Services Administration


Related activities
1.25 AMA PRA

Test Your HIV Management Skills Across the Spectrum of Care: From Newly Diagnosed to Aging Patients With HIV

An Immersive Patient and Provider Simulation

Faculty: Seble G. Kassaye, MD, MS; Sarah E. Rowan, MD
Release: 10/15/2021
Expiration: 10/15/2022